Global Eicosapentaenoic Acid Market By Form (Triglycerides and Ethyl Esters), Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Others), Source (Anchovy/Sardine Oil, High Concentrates, Medium Concentrates, Low Concentrates, Algae Oil, Tuna Oil, Cod Liver Oil, Salmon Oil, Krill Oil, Menhaden Oil), – Industry Trends and Forecast to 2029
Market Analysis and Size
Globally, EPA is becoming more important and is becoming a part of the consumer's daily diet. The primary causes of this shift are the increased prevalence of lifestyle diseases and people practicing preventive healthcare. Furthermore, the emerging applications of EPA in food, dietary supplements, and clinical nutrition have fuelled market growth.
Data Bridge Market Research analyses that the eicosapentaenoic acid market was valued at USD 1.6 billion in 2021 and is expected to reach the value of USD 3.82 billion by 2029, at a CAGR of 11.50% during the forecast period of 2022-2029.
Market Definition
EPA (eicosapentaenoic acid) is long-chain omega-3 fatty acids found in plants and animals. EPA (eicosapentaenoic acid) are essential fatty acids required for human health. These fatty acids are essential for brain function as well as human growth and development. Eicosapentaenoic acid fatty acid consumption lowers the risk of chronic diseases such as cancer, heart disease, and arthritis.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Form (Triglycerides and Ethyl Esters), Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Others), Source (Anchovy/Sardine Oil, High Concentrates, Medium Concentrates, Low Concentrates, Algae Oil, Tuna Oil, Cod Liver Oil, Salmon Oil, Krill Oil, Menhaden Oil)
|
|
Countries Covered
|
U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
DSM (Netherlands), BASF SE (Germany), Lonza Group (Switzerland), Glanbia Plc (Ireland), ADM (US), Farbest Brands (US), SternVitamin GmbH & Co. KG (Germany), Adisseo (France), BTSA Biotechnologias Aplicadas S.L. (Spain), Rabar Pty Ltd (Australia), Orkla Health (Norway), Epax (norway), BioProcess Algae LLC (U.S), Croda International plc (U.K)
|
|
Opportunities
|
|
Eicosapentaenoic Acid Market Dynamics
Drivers
- Rising health awareness of consumption eicosapentaenoic acids
The eicosapentaenoic acid helps to reduce the risk of abnormal heartbeats or arrhythmias, which can result in the patient's sudden death. It also aids in the reduction of triglyceride levels, the slowing of the growth rate of atherosclerotic plaque, and the reduction of blood pressure. Consumers are increasingly shifting to healthier alternatives while viewing preventive care as a necessary tool to assist them in leading a healthier lifestyle. As a result, eicosapentaenoic acids are becoming more popular because they are a good source of vitamins, proteins, and minerals and can help with diseases like cancer, asthma, and depression.
- Marketing strategies and endorsements to boost market growth
Brand name, nutritional value, and product safety are all factors that influence consumer purchasing decisions. The benefits of eicosapentaenoic acid-based supplements are likely to influence purchasing behaviour through various forms of media, including electronic and print.. Fish consumption is expected to rise further, particularly in developing countries. Fish oil is the primary source of eicosapentaenoic acids.
Opportunity
The increasing use of eicosapentaenoic acid in pet food and pharmaceuticals, as well as increased public initiatives related to health and fitness, are boosting the market. Consumer awareness of the health benefits of eicosapentaenoic acid is increasing the need for market players to innovate in order to compete. On the other hand, the technology delivers odorous oils in a micro-emulsified formulation that is designed to increase surface absorption.
Restraints
However, uneven fish capture and rising demand for fish from other application sources reduce their availability at a lower cost, limiting market growth. Increasing environmental, metal, and hazardous pollutants in fish are making them toxic for consumption, which is expected to limit the segment's growth. Furthermore, increased regulations on fishing activities to protect fish species are expected to have an impact on the industry's raw material supply.
This eicosapentaenoic acid market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the eicosapentaenoic acid market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Eicosapentaenoic Acid Market
The pandemic has impacted the entire food system, exposing its vulnerability. Border closures, trade restrictions, and confinement measures have made it difficult for EPA and DHA manufacturers to access markets, including buying inputs and selling their products, disrupting domestic and international food supply chains. Despite supply chain disruptions, the covid-19 has significantly accelerated global demand for bioactive ingredients such as EPA and DHA in response to rising consumer demand for fortified foods and beverages as well as dietary supplements.
Recent Development
- KD Pharma Group will launch Alga3, a sustainable, vegan omega-3 solution, in September 2021. The superior technology and production flexibility of KD Nutra allow for a diverse range of omega-3 concentrates. This means that the companies can tailor the EPA and DHA ratio to meet the needs of their customers, and for every kd-pür fish oil, there is an Alga3TM plant-based solution.
- Polaris launched Omegavie DHA 800 Sensory Qualitysilver 5 algae, an algae oil sourced from microalgae (Schizochytrium sp.) that is rich in vitamins, proteins, pigments, and enzymes, in June 2021. The ingredient provided a plant-based, sustainable source of polyunsaturated fatty acids (PUFAs).
- In May 2020, DSM unveiled life'sDHASF55-O200DS, a novel plant-based and high-quality docosahexaenoic acid (DHA) oil for maternal and early life nutrition solutions. According to DSM, the algae-derived ingredient contains at least 550 mg/g of natural triglyceride DHA, which is more potent than some other sources.
Global Eicosapentaenoic Acid Market Scope
The eicosapentaenoic acid market is segmented on the basis of form, application and source. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Form
- Triglycerides
- Ethyl Esters
Source
- Anchovy/Sardine Oil
- High Concentrates
- Medium Concentrates
- Low Concentrates
- Algae Oil
- Tuna Oil
- Cod Liver Oil
- Salmon Oil
- Krill Oil
- Menhaden Oil
Application
- Infant formula
- Fortified Food & beverages
- Nutritional supplement
- Pharmaceutical
- Clinical nutrition
- Dietary supplements
Eicosapentaenoic Acid Market Regional Analysis/Insights
The eicosapentaenoic acid market is analysed and market size insights and trends are provided by country, form, application and source as referenced above.
The countries covered in the eicosapentaenoic acid market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the eicosapentaenoic acid market due to the increasing occurrences of chronic diseases, as well as the prevalence of improved medication and better health supplements, whereas Europe is expected to grow from 2022 to 2029 due to the growing geriatric population, as well as rising usage in treating obesity.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Eicosapentaenoic Acid Market Share Analysis
The eicosapentaenoic acid market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to eicosapentaenoic acid market.
Some of the major players operating in the eicosapentaenoic acid market are:
- DSM (Netherlands)
- BASF SE (Germany)
- Lonza Group (Switzerland)
- Glanbia Plc (Ireland)
- ADM (US)
- Farbest Brands (US)
- SternVitamin GmbH & Co. KG (Germany)
- Adisseo (France)
- BTSA Biotechnologias Aplicadas S.L. (Spain)
- Rabar Pty Ltd (Australia)
- Orkla Health (Norway)
- Epax (norway)
- BioProcess Algae LLC (U.S)
- Croda International plc (U.K)
SKU-
